Sarah Urnauer

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Correction: Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expression.

Correction: Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expression.

Journal: Gene therapy
Published: July 11, 2024

The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.

The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.

Journal: EJNMMI research
Published: October 07, 2021

Regional Hyperthermia Enhances Mesenchymal Stem Cell Recruitment to Tumor Stroma: Implications for Mesenchymal Stem Cell-Based Tumor Therapy.

Regional Hyperthermia Enhances Mesenchymal Stem Cell Recruitment to Tumor Stroma: Implications for Mesenchymal Stem Cell-Based Tumor Therapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 05, 2020

Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.

Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.

Journal: Thyroid : official journal of the American Thyroid Association
Published: December 10, 2019

Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (NIS) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cells.

Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (NIS) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cells.

Journal: Theranostics
Published: October 25, 2019

Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expression.

Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expression.

Journal: Gene therapy
Published: August 11, 2018

TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer.

TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer.

Journal: Endocrine-related cancer
Published: July 25, 2018

External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery.

External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery.

Journal: Human gene therapy
Published: May 05, 2018

A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery.

A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery.

Journal: Molecular cancer research : MCR
Published: February 23, 2018

EGFR Targeting and Shielding of pDNA Lipopolyplexes via Bivalent Attachment of a Sequence-Defined PEG Agent.

EGFR Targeting and Shielding of pDNA Lipopolyplexes via Bivalent Attachment of a Sequence-Defined PEG Agent.

Journal: Macromolecular bioscience
Published: June 08, 2017

EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.

EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.

Journal: Oncotarget
Published: April 26, 2017

Influence of Defined Hydrophilic Blocks within Oligoaminoamide Copolymers: Compaction versus Shielding of pDNA Nanoparticles.

Influence of Defined Hydrophilic Blocks within Oligoaminoamide Copolymers: Compaction versus Shielding of pDNA Nanoparticles.

Journal: Polymers
Published: March 15, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026